News
Stay informed
Below you will find all the latest news on Andera Partners, its teams and its investments.
Andera Partners co-leads $25m extension round for FIRE1
Flamingo Therapeutics and Dynacure Announce Merger to Create Leading RNA Therapeutics Company Focuse…
2022 Report – Andera Partners
Andera Partners Portfolio Company Mineralys Therapeutics Successfully Completes Upsized $192 Million…
Agomab Reports Positive Phase 1 Results with AGMB-129, a GI-restricted ALK5 Inhibitor for Fibrosteno…
Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics
Andera Partners reaches its €600 million target for Andera MidCap 5
Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatmen…
Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma
Andera Partners opens its Milan office
KLUBB Group acquires Isoli S.p.A.
T-knife Therapeutics Announces Dosing of First Patient with TK-8001 in the IMAG1NE Phase 1/2 Clinica…
Andera Partners invests in a high-performance detection solutions company Senstronic
New governance for Andera Partners
Andera Partners raises its largest life sciences fund at €456M, demonstrating the attractiveness of…
Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic…
JenaValve Completes Enrollment in the ALIGN-ARIDE Clinical Trial
TRiCares Raises €47m in a First Closing of its Series C
Agomab Therapeutics Selected as One of Fierce Biotech’s “Fierce 15” Companies of 2…
French electric vehicle charging points market
Maritim Mobility
Datacenters
Heat, the forsaken vector of a renewable future
Green hydrogen will fuel tomorrow’s economy
Medical Microinstruments Secures $75M to Advance Robotic Microsurgery
Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114M
Andera Partners strengthens its Life Sciences team with a new partner
Annual CSR Report 2021 / Rapport Annuel RSE 2021
ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Validation of…
Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to…
TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replace…
Andera Partners announces the intermediate closing of its new fund Andera MidCap 5 at €450m
HR Path receives €225 million in Financing
Andera Partners supports Tubulis in a €60 million Series B financing to accelerate the development o…
Andera Partners to support ElaN Group, the leading technology platform for translation services in t…
Successful first in human implantation of Topaz Tricuspid Heart Valve Replacement System
Andera Partners to sell its Life Sciences’ portfolio company ReViral to Pfizer
Andera Partners and Compagnie Lebon launch a co-investment activity
Andera Partners announces two promotions to Partner and several appointments to strengthen its teams
Evommune Initiates Phase 1 Study to Evaluate Safety of EVO101, an IRAK4 Inhibitor, in Healthy Volunt…
Andera Partners creates Andera Partners Transformation A unique support platform in private equity i…
Andera Partners supports TargED Biopharmaceuticals in €39 million Series A financing to bring ground…
With nearly €550 million deployed, Andera Partners experienced a record year in 2021
Andera Partners invests in green renewable hydrogen production company Lhyfe
JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited
Allecra Therapeutics and ADVANZ PHARMA Sign Exclusive License and Supply Agreement for Allecra’s Ant…
BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision i…
Andera Partners announces 1st closing at €84m for Andera Smart Infra 1
Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
Andera Partners supports the Founder of ENACO Group in the acquisition of its entire share capital a…
Agomab Therapeutics to Acquire Origo Biopharma
Andera Partners supports Exciva in a Series A to fight Alzheimer’s disease
The role of private equity in the recovery in France and Europe: an opportunity for investors
Andera Partners leads Amolyt Pharma’s $80 million Series B alongside Sectoral Asset Management
Andera Acto supports DP Software Group in its development strategy
Andera Partners leads US$ 83 million series A round in Evommune Inc. for the development of transfor…
Andera Partners strengthens its investment teams and reaffirms its growth ambition
T-knife Announces $110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies
Artios Pharma has completed a $153 million series C
Andera Partners and the KLUBB Group’s founder join forces
Andera Partners publishes its first Climate & Sustainability Report
Andera Expansion acquires MC2 Technologies
Andera Partners sells its majority stake in Infra Group
Andera MidCap sells its stake in Minafin
TRiCares announces the successful first in human implantations of “Topaz”
Poxel announces the approval of Twymeeg
Andera sells its stake in Netco Group
Life Sciences portfolio company Gamamabs signs an agreement with Exelixis
Andera Partners strengthens its presence in the DACH region
Internship offer – Infrastructure investment
Artios Pharma announces collaboration with Novartis
Andera creates its own foundation
Andera Partners announces the arrival of Noëlla de Bermingham as Chief Sustainability Officer
ReViral and LianBio Announce Exclusive Collaboration
Pusterla 1880 issues Sustainability-Linked Bonds to finance its growth
Our 5th area of activity: Andera Infra
MedLumics closes upsized EUR 18M financing round and appoints new Chairman
Andera strengthens governance and targets €4-5 billion in AUM by 2025
Andera MidCap sells Skill & You to IK Investment Partners
MMI appoints healthcare industry veteran Mark Toland as CEO
Andera MidCap invests in Pusterla 1880
AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial
Andera sells its Life Sciences’ portfolio company Arvelle Therapeutics
Inotrem’s COVID-19 Phase IIa Clinical Trial declared “National Priority Research” by the French gove…
Significant agreements with Chinese market leaders in our Life Sciences portfolio
Andera Partners renames all its activities
The Power of And
Medlumics lands a 14M€ new financing round
Reviral raises $44 million in Series C financing
T-knife completes €66m Series A financing
COVID-19: assessing nangibotide in mechanically ventilated patients with COVID-19
ActoMezz IV: a single closing at more than €500 million
BioDiscovery sells Corvidia to Novo Nordisk
Appointment of Michael H. Carrel as chairman of the Axonics board of directors.
Axonics Modulation Technologies reports financial results for the 1st quarter 2020 and provides an…
Andera Partners welcomes Constance Jay and strengthens its Investor Relations
Dynacure Announces €50M ($55M) Series C Financing
AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI
Newsletter – 03/2020
Allecra Therapeutics announces positive top-Line results for phase 3 ALLIUM clinical trial of EXBLIF…
2019: a new record year for Andera
Inotrem Announces Enrollment of First Patient in its Phase IIb Trial in the Treatment of Septic Shoc…
Hans Van de Velde – Senior Advisor Belgium
BioDiscovery invests in AgomAb Therapeutics
BioDiscovery co-leads $133 million Financing in AM-Pharma B.V.
The ORCA Group acquires Italian companies Angeloni and Impregnatex
ic20: Initiative Climate 2020
Winch invests in Spherea
Winch invests in the Belgian company Infra Group
ActoMezz invests in Tournus
Appointments and Recruitments
A syndicate of international investors finance Arvelle Therapeutics
Grey Wolf Therapeutics completes £10 million series A financing with Andera Partners and Canaan
NetCo welcomes IK among its shareholders, alongside Andera and the founding family
2018: an emblematic year for Andera Partners
Winch Capital 4: fundraising completed at €445 million
Crescendo Biologics announces early licensing by Takeda
Promising results for the lead program of Genkyotex (BioDiscovery 3) in a fibrotic orphan disease
Artios Pharma Announces $86 million (£65 million) Series B Financing
WINCH Capital 4: a first closing of €360m for Andera Partners mid-cap fund
BioDiscovery invests in Dynacure to advance lead program into clinical development
Renewed governance for Andera Partners
ENYO Pharma raises €40 million in Series B fundraising
TRiCares Closes €22 Million ($25.4 Million) Series B Financing Round to Fund Development of Minimall…
GamaMabs Pharma to present at 2018 ASCO annual meeting results from the First-In-Human clinical stud…
Crescendo Biologics Ltd. raises $70 Million (€57 Million) in Series B financing
Andera Partners sponsors the carve-out of Conduent’s Off-Street Parking business in association with…
Corvidia Therapeutics Secures $60 Million in Series B Funding
EdRIP becomes ANDERA PARTNERS
Sorry, no results.
